Published in Brain Res Mol Brain Res on March 31, 2001
Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: implications for linkage-disequilibrium gene mapping. Am J Hum Genet (2003) 4.58
Localization and targeting of voltage-dependent ion channels in mammalian central neurons. Physiol Rev (2008) 2.90
Developmental neurotoxicity of pyrethroid insecticides: critical review and future research needs. Environ Health Perspect (2005) 2.01
Molecular mechanisms of pyrethroid insecticide neurotoxicity: recent advances. Arch Toxicol (2011) 1.82
Neurological perspectives on voltage-gated sodium channels. Brain (2012) 1.62
Sodium channel SCN1A and epilepsy: mutations and mechanisms. Epilepsia (2010) 1.59
A whole-genome scan and fine-mapping linkage study of auditory-visual synesthesia reveals evidence of linkage to chromosomes 2q24, 5q33, 6p12, and 12p12. Am J Hum Genet (2009) 1.50
Functional properties and differential neuromodulation of Na(v)1.6 channels. Mol Cell Neurosci (2008) 1.47
Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy. Neurosci Lett (2008) 1.40
A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS+) mutation. Neurobiol Dis (2009) 1.32
The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br J Ophthalmol (2004) 1.25
Divergent sodium channel defects in familial hemiplegic migraine. Proc Natl Acad Sci U S A (2008) 1.13
Human and rat Nav1.3 voltage-gated sodium channels differ in inactivation properties and sensitivity to the pyrethroid insecticide tefluthrin. Neurotoxicology (2008) 1.09
Sodium channels, the electrogenisome and the electrogenistat: lessons and questions from the clinic. J Physiol (2012) 1.05
Isoflurane depresses hippocampal CA1 glutamate nerve terminals without inhibiting fiber volleys. BMC Neurosci (2006) 1.03
Divergent actions of the pyrethroid insecticides S-bioallethrin, tefluthrin, and deltamethrin on rat Na(v)1.6 sodium channels. Toxicol Appl Pharmacol (2010) 0.99
Analysis and optimization of pulse dynamics for magnetic stimulation. PLoS One (2013) 0.92
Expansion of voltage-dependent Na+ channel gene family in early tetrapods coincided with the emergence of terrestriality and increased brain complexity. Mol Biol Evol (2010) 0.92
Molecular requirements for recognition of brain voltage-gated sodium channels by scorpion alpha-toxins. J Biol Chem (2009) 0.92
Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance. Neurobiol Dis (2014) 0.89
The potential role of lamotrigine in schizophrenia. Psychopharmacology (Berl) (2005) 0.87
Genomic biomarkers of SUDEP in brain and heart. Epilepsy Behav (2013) 0.87
Properties of human brain sodium channel α-subunits expressed in HEK293 cells and their modulation by carbamazepine, phenytoin and lamotrigine. Br J Pharmacol (2014) 0.85
Actions of Tefluthrin on Rat Na(v)1.7 Voltage-Gated Sodium Channels Expressed in Xenopus Oocytes. Pestic Biochem Physiol (2011) 0.84
Functional expression of Rat Nav1.6 voltage-gated sodium channels in HEK293 cells: modulation by the auxiliary β1 subunit. PLoS One (2014) 0.84
Molecular identity of axonal sodium channels in human cortical pyramidal cells. Front Cell Neurosci (2014) 0.84
Differential state-dependent modification of rat Na(v)1.6 sodium channels expressed in human embryonic kidney (HEK293) cells by the pyrethroid insecticides tefluthrin and deltamethrin. Toxicol Appl Pharmacol (2011) 0.83
Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. Channels (Austin) (2013) 0.81
Clinical utility of neuronal cells directly converted from fibroblasts of patients for neuropsychiatric disorders: studies of lysosomal storage diseases and channelopathy. Curr Mol Med (2015) 0.79
From Squid to Mammals with the HH Model through the Nav Channels' Half-Activation-Voltage Parameter. PLoS One (2015) 0.78
Severe Myoclonic Epilepsy in Infancy - Adult Phenotype with Bradykinesia, Hypomimia, and Perseverative Behavior: Report of Five Cases. Mol Syndromol (2011) 0.77
Effects of the β1 auxiliary subunit on modification of Rat Nav1.6 sodium channels expressed in HEK293 cells by the pyrethroid insecticides tefluthrin and deltamethrin. Toxicol Appl Pharmacol (2015) 0.77
Functional reconstitution of rat Nav1.6 sodium channels in vitro for studies of pyrethroid action. Neurotoxicology (2016) 0.76
SCN3A deficiency associated with increased seizure susceptibility. Neurobiol Dis (2017) 0.75
Gene expression profile of sodium channel subunits in the anterior cingulate cortex during experimental paclitaxel-induced neuropathic pain in mice. PeerJ (2016) 0.75
Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis. J Med Chem (2014) 0.75
Dysarthria and broader motor speech deficits in Dravet syndrome. Neurology (2017) 0.75
Ototrauma induces sodium channel plasticity in auditory afferent neurons. Mol Cell Neurosci (2011) 0.75
Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci (1995) 3.65
The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience (1989) 3.57
Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A (1995) 3.28
Foreign gene expression in yeast: a review. Yeast (1992) 3.20
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience (1997) 2.56
Multiple opiate receptor sites on primary afferent fibres. Nature (1980) 2.34
Molecular determinants of voltage-dependent gating and binding of pore-blocking drugs in transmembrane segment IIIS6 of the Na(+) channel alpha subunit. J Biol Chem (2001) 2.20
Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res (1997) 2.08
Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J Neurosci (1990) 1.96
Intracellular recording of identified neostriatal patch and matrix spiny cells in a slice preparation preserving cortical inputs. J Neurophysiol (1989) 1.81
Two classes of cortical GABA neurons defined by differential calcium binding protein immunoreactivities. Exp Brain Res (1989) 1.77
Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol Pharmacol (2000) 1.76
AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J Neurosci Methods (1980) 1.74
Neuroprotective effects of adenosine. Trends Pharmacol Sci (1988) 1.69
Efferent connections and nigral afferents of the nucleus accumbens septi in the rat. Neuroscience (1978) 1.57
The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience (2000) 1.55
Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol Psychiatry (2000) 1.54
Upregulation of a silent sodium channel after peripheral, but not central, nerve injury in DRG neurons. J Neurophysiol (1999) 1.53
Biochemical and anatomical observations on the degeneration of peptide-containing primary afferent neurons after neonatal capsaicin. Neuroscience (1981) 1.50
Gene expression profiling in the post-mortem human brain--no cause for dismay. J Chem Neuroanat (2001) 1.36
The GABAB receptor interacts directly with the related transcription factors CREB2 and ATFx. Proc Natl Acad Sci U S A (2000) 1.36
The upstream activation site of a Ty2 element of yeast is necessary but not sufficient to promote maximal transcription of the element. Proc Natl Acad Sci U S A (1987) 1.35
Distribution of voltage-gated sodium channel alpha-subunit and beta-subunit mRNAs in human hippocampal formation, cortex, and cerebellum. J Comp Neurol (2000) 1.34
Expression pattern of human P2Y receptor subtypes: a quantitative reverse transcription-polymerase chain reaction study. Biochim Biophys Acta (2001) 1.33
Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease. Neuroscience (1996) 1.30
Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J Neurochem (1994) 1.29
The binding of [3H]mepyramine to histamine H1 receptors in guinea-pig brain. J Neurochem (1978) 1.28
Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system--II. Immunohistochemical analysis. Neuroscience (1986) 1.28
Relationship of neuronal nitric oxide synthase immunoreactivity to GnRH neurons in the ovariectomized and intact female rat. J Neuroendocrinol (1996) 1.27
Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA. Nucleic Acids Res (1991) 1.27
Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin. Neuroscience (1989) 1.26
An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res (1985) 1.25
Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression. Neuroscience (1999) 1.25
Mice with very low expression of the vesicular monoamine transporter 2 gene survive into adulthood: potential mouse model for parkinsonism. Mol Cell Biol (2001) 1.24
Neuropeptide-containing neurons of the cerebral cortex are also GABAergic. Proc Natl Acad Sci U S A (1984) 1.24
Functional coupling of mammalian receptors to the yeast mating pathway using novel yeast/mammalian G protein alpha-subunit chimeras. Yeast (2000) 1.24
Stable transfection of calbindin-D28k into the GH3 cell line alters calcium currents and intracellular calcium homeostasis. Neuron (1992) 1.22
Rapid selection using G418 of high copy number transformants of Pichia pastoris for high-level foreign gene expression. Biotechnology (N Y) (1994) 1.22
The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. Br J Pharmacol (2009) 1.22
Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neurosci Lett (1980) 1.21
Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression. Proc Natl Acad Sci U S A (1996) 1.19
Distribution, pathways and reactions to drug treatment of nerves with neuropeptide Y- and pancreatic polypeptide-like immunoreactivity in the guinea-pig digestive tract. Cell Tissue Res (1983) 1.18
Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Ann Neurol (1997) 1.18
Effect of calcitonin gene-related peptide on contraction of striated muscle in the mouse. Neurosci Lett (1985) 1.17
Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease. Arch Neurol (2000) 1.17
An immunohistochemical study of neuronal populations containing neuropeptides or gamma-aminobutyrate within the superficial layers of the rat dorsal horn. Neuroscience (1981) 1.16
Cell-specific immuno-probes for the brain of normal and mutant Drosophila melanogaster. I. Wildtype visual system. Cell Tissue Res (1988) 1.16
Functional modulation of human brain Nav1.3 sodium channels, expressed in mammalian cells, by auxiliary beta 1, beta 2 and beta 3 subunits. Neuroscience (2002) 1.15
Enkephalin-, VIP- and substance P-like immunoreactivity in the carotid body. Nature (1980) 1.15
The intracellular production and secretion of HIV-1 envelope protein in the methylotrophic yeast Pichia pastoris. Gene (1993) 1.13
Morphology, distribution, and synaptic relations of somatostatin- and neuropeptide Y-immunoreactive neurons in rat and monkey neocortex. J Neurosci (1984) 1.13
Substance P containing and cholinergic projections from the habenula. Brain Res (1978) 1.12
Insulin-like growth factor-1 reduces postischemic white matter injury in fetal sheep. J Cereb Blood Flow Metab (2001) 1.12
In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport (1995) 1.12
Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels. Neuropharmacology (2003) 1.10
Nerve growth factor counteracts the neurophysiological and neurochemical effects of chronic sciatic nerve section. Brain Res (1985) 1.10
GAP-43 expression in primary sensory neurons following central axotomy. J Neurosci (1994) 1.09
D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience (1990) 1.09
Changes in the mRNAs encoding voltage-gated sodium channel types II and III in human epileptic hippocampus. Neuroscience (2001) 1.06
Cloning, pharmacology, and tissue distribution of G-protein-coupled receptor GPR105 (KIAA0001) rodent orthologs. Genomics (2001) 1.06
Distribution of calcitonin gene-related peptide in the rat peripheral nervous system with reference to its coexistence with substance P. Neuroscience (1985) 1.05
Distribution of vasoactive intestinal polypeptide in the rat and mouse brain. Neuroscience (1979) 1.05
The organization and collateralization of corticostriate neurones in the motor and sensory cortex of the rat brain. Brain Res (1987) 1.05
Cloning, distribution and functional analysis of the type III sodium channel from human brain. Eur J Neurosci (2000) 1.04
Loss of calbindin-28K immunoreactive neurones from the cortex in Alzheimer-type dementia. Brain Res (1988) 1.04
Ontological study of calbindin-D28k-like and parvalbumin-like immunoreactivities in rat spinal cord and dorsal root ganglia. J Comp Neurol (1990) 1.03
Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics (2001) 1.03
Characterization of [(3)H]Quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections. J Neurochem (2000) 1.02
Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. Brain Res Mol Brain Res (1998) 1.02
N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Res (2000) 1.01
Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum. Neuroscience (1998) 1.01
Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog Neurobiol (2000) 1.01
Parvalbumin-containing GABAergic interneurons in the rat neostriatum. J Comp Neurol (1990) 1.01
Connexin expression in Huntington's diseased human brain. Cell Biol Int (1998) 1.00
Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Res (1996) 1.00
Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study. Neuroscience (1996) 1.00
Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease. Brain Res Bull (2001) 1.00
Electrophysiological and pharmacological properties of the human brain type IIA Na+ channel expressed in a stable mammalian cell line. Pflugers Arch (2001) 1.00
Apposition of neuronal elements containing nitric oxide synthase and glutamate in the nucleus tractus solitarii of rat: a confocal microscopic analysis. Neuroscience (2000) 0.99
Amyloid-like inclusions in Huntington's disease. Neuroscience (2000) 0.99
Vasoactive intestinal polypeptide (VIP): vesicular localization and potassium evoked release from rat hypothalamus. Brain Res (1978) 0.99
Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia. Neuroreport (2000) 0.98
The regional distribution and chromatographic characterisation of neurotensin-like immunoreactivity in the rat central nervous system. J Neurochem (1982) 0.98
Distribution of putative neurotransmitters in the neocortex. Neuroscience (1979) 0.97
Coexistence of calcitonin gene-related peptide and substance P-like peptide in single cells of the trigeminal ganglion of the rat: immunohistochemical analysis. Brain Res (1985) 0.97
GABA(B) receptor heterodimer-component localisation in human brain. Brain Res Mol Brain Res (2000) 0.97